Illumina Inc $135.45

down -0.77


17/4/2014 08:10 PM  |  NASDAQ : ILMN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ILMN Trend Analysis - it has outperformed the S&P 500 by 115%

Partner Headlines

  1. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  2. How To Tweak Your Retirement Portfolio For 2014 Market

    IBD
  3. Medical Research Providers Ride Higher With Biotechs

    IBD
  4. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  5. Gap-Ups Point To Strength Among Select Big Caps

    IBD
  6. Illumina Inc: How Long Can a Miracle Go On?

    GuruFocus
  7. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  8. Facebook, Biogen, Sands Among Top Big Caps Reporting

    IBD
  9. ILLUMINA

    IBD
  10. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  11. Illumina Details Its Strategy; Stock Jumps Again

    IBD
  12. US Stock Futures Surge Ahead Of Morgan Stanley Earnings

    Benzinga
  13. Illumina Announces New Organizational Alignment -8K

    Benzinga
  14. Market Wrap For January 16: Markets End Two Day Winning Streak

    Benzinga
  15. ILLUMINA

    IBD
  16. Illumina Upbeat On Q4, 2014

    IBD
  17. Illumina, Regeneron, Intuitive Q4 Results Impress

    IBD
  18. Year in Review: 2013 Innovations

    FoxBusiness
  19. Year in Review: 2013 Innovations

    FoxBusiness
  20. Benzinga's Top Initiations

    Benzinga
  21. Illumina Receives FDA Premarket Clearance for MiSeqDx System

    Benzinga
  22. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    Benzinga
  23. Illumina Appoints Francis deSouza as President

    Benzinga
  24. Syntrix Biosystems Announces Court Upholds $115M Patent Infringement Judgement ...

    Benzinga
  25. Vipshop, 3D Systems Lead Top 5 Outperforming Stocks

    IBD
  26. Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing and Aggregating ...

    Benzinga
  27. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, ...

    Benzinga
  28. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  29. Illumina Announces TruGenome Undiagnosed Disease Test

    Benzinga
  30. Illumina Tops Q3 Profit, Sales

    IBD
  31. Illumina Earnings, Guidance Beat Estimates Yet Again

    IBD
  32. Earnings Scheduled For October 21, 2013

    Benzinga
  33. Illumina Collaborates with University of Cambridge, Genomics England

    Benzinga
  34. Illumina's Verinata Health Reports Expanded Test of Verifi for Option to ...

    Benzinga
  35. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  36. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, CELG, REGN)

    Benzinga
  37. Illumina Applies CE Mark to Expanded MiSeqDx™ System

    Benzinga
  38. Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 Ccorrectly ...

    Benzinga
  39. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, ...

    Benzinga
  40. UPDATE: Wells Fargo Initiates Coverage on Illumina on Prime Market Position

    Benzinga
  41. Sony and Illumina Set to Change the Way Doctors Identify and Treat Cancer ...

    Benzinga
  42. Illumina to Supply Natera with Sequencing Instruments, Consumables for ...

    Benzinga
  43. Drug R&D Suppliers Deliver

    IBD
  44. Medical Research Firms Tap Drug Development Trend

    IBD
  45. Medical Research Firms Tap Drug Development Trend

    IBD
  46. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)

    Benzinga
  47. Illumina, Grifols, Acadia Resist The Correction

    IBD
  48. Benzinga's M&A Chatter for Monday August 12, 2013

    Benzinga
  49. Baron Funds Comments on Illumina Inc.

    GuruFocus
  50. Baron Funds Comments on Illumina Inc.

    GuruFocus
Trading Center